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ABSTRACT 
Genetic Characterization of Single-Stranded RNA Phage Lysis Genes   
 
Jennifer Tran 
Department of Biochemistry and Biophysics 
Texas A&M University 
 
Research Advisor: Dr. Ry Young 
Department of Biochemistry and Biophysics 
Texas A&M University 
 
 
 With an ever-increasing incidence of antibiotic resistance in clinical settings, bacterial 
viruses, or “phages”, are being considered as alternatives to chemical antibiotics. One type of 
phage in particular, single-stranded RNA (ssRNA) phages, are of interest because they have 
single gene lysis systems, meaning they employ one gene that, when expressed, causes the host 
cell to lyse. There are four paradigm single gene lysis systems: L from ssRNA phage MS2, A2 
from ssRNA phage Qβ, E from single-stranded DNA phage ϕX174, and Lys from ssRNA phage 
M. While the mechanism of L is still unknown, lysis proteins A2, E, and Lys have been shown to 
inhibit steps in peptidoglycan biosynthesis. It is highly likely that lysis proteins from other 
ssRNA phages also target this pathway. Previously, however, only fourteen single-stranded RNA 
phages were known. Two separate papers published within the past year have identified over 150 
novel ssRNA phage genomes by mining transcriptome and microbiome data (2, 3). The goal of 
this project is to identify and test potential lysis genes from these genomes and determine the 
targets of their lysis proteins. Understanding the mechanisms of these novel lysis proteins would 
potentially allow us to find new antibiotic targets or even develop new antibiotic strategies. 
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NOMENCLATURE 
 
dsDNA Double-stranded DNA 
LB  Lysogeny broth 
LPS  Lipopolysaccharide 
OD  Optical density 
PG  Peptidoglycan 
ssDNA Single-stranded DNA 
ssRNA  Single-stranded RNA 
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CHAPTER I 
INTRODUCTION 
Overview of bacteriophages 
Bacteriophages, literally meaning “bacteria eater” in Greek, are the viruses which infect 
bacteria. Also called phages, these viruses are ubiquitous in the environment, with the number of 
phage particles estimated to be 1031 in the biosphere and outnumbering bacteria nearly tenfold 
(4).  
Phages were first observed over a century ago by Frederick Twort as round clearings in 
bacterial growth. Two years later, in 1917, Felix d’Herelle independently observed similar 
clearings on Shigella dysenteriae, the bacteria which causes dysentery, and coined the term 
bacteriophage (5). At the time antibiotics had not yet been discovered, and d’Herelle was the first 
to use phage as a therapeutic to treat bacterial disease (6). In fact, despite controversy about 
d’Herelle’s findings in the Western scientific community, phage therapy was used commercially 
and advertised in medicine up until the advent of penicillin, when it was abandoned nearly 
everywhere except the Soviet Union (where they used phage as a treatment through World War 
II) (7). However, phages still had an essential role in basic science, leading to monumental 
discoveries in molecular biology and genetics.  
Max Delbrück, a physicist at Caltech studying the physical nature of the gene, was 
introduced to bacteriophages as a more convenient model organism than Drosophila, and began 
to work with phage replication, collaborating with fellow researchers Salvador Luria and Alfred 
Hershey. The three started what came to be known as the Phage Group, offering courses at the 
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Cold Spring Harbor Laboratory in New York. The research that emerged from this group led to a 
greater understanding of mutation, the identification of DNA as the hereditary material, the use 
of phage for genetic recombination, and more (8). More recently, phage display has been 
instrumental in creating screening libraries in immunology, and CRISPR/Cas systems – a 
bacterial version of adaptive immunity to protect against repeat phage attacks – have wide future 
implications in genetic editing. 
Phages are entering back into medicine in recent years though, due to the worrying rise in 
antibiotic-resistant microbes, and researchers have recently found bacterial strains resistant to 
colistin, a drug of last resort (9). While the need for novel antibiotic classes increases, the 
development and release of these drugs has slowed considerably. Bacteriophages may be the key 
to new therapeutic strategies and finding novel antibiotic targets. 
Phage morphology 
 Typically, bacteriophages are characterized into three loose groups: tailed, double-
stranded DNA (dsDNA) phages of the order Caudovirales; double-stranded, lipid-containing 
phages; and single-stranded phages with small genomes, a rather diverse category (10). Of the 
bacteriophages isolated thus far, 96% of them are tailed, dsDNA phages while the remaining 4% 
is split between the other types of phages (11).  
Phages in this group typically have icosahedral capsids or heads encapsulating the DNA, 
a tail with proteins to facilitate attachment to the host and genome entry, and tail fibers, which 
also aid in adsorption to the host. This group has been further organized by tail morphology, into 
three classes. Myophages such as phage T4 have long tails, which contract upon injection of 
DNA, and siphophages such as phage λ are have long, often flexible tails that are noncontractile. 
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The third class consists of podophages like P22, which have short tails (12). The genomes of 
these phages are diverse and range from ~14 kb to ~400 kb, with the exception of Mycoplasma 
virus P1, a podophage with a genome size of under 12 kb (10). 
Lipid-containing bacteriophages consists of four families of phages with diverse 
morphologies: Corticoviridae (icosahedral), Tectiviridae (icosahedral), Cystoviridae (spherical), 
and Plasmaviridae (pleomorphic). With genomes around 10 to 16 kb in length, these phages all 
contain lipids, derived from host cytoplasmic membranes and either enclosed within the capsid 
or form the outer layer of the virion (13).  
 The single-stranded phages with short genomes has two very distinct phage 
morphologies. Both ssRNA phages and ssDNA phages in the family Microviridae are small, 
tailless, and have icosahedral heads. Single-stranded RNA phages are the smallest viruses known 
and have short ssRNA genomes of approximately 4 kb. Similarly, phages in Microviridae have 
small ssDNA genomes of 4 to 6 kb, but encode for spike proteins on the capsid which ssRNA 
phages do not have. In stark contrast, filamentous phages do not have a capsid, instead consisting 
of long, thin filaments encasing the circular ssDNA genomes. These phages do not kill their host 
upon release of virions like the other phages, instead secreting from the membrane. 
Bacteriophage life cycle 
 The bacteriophage life cycle starts with infection, recognizing receptors on the host cell, 
adsorbing, and then injecting its genome. In stark contrast to a broad-spectrum antibiotic 
approach, phages interact with specific receptors on bacterial hosts, and slight differences in 
those receptor proteins – even from one strain to the next – can affect phages’ ability to infect 
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(14). Because of the difference in chemical composition and structure of the cell wall between 
Gram-positive and Gram-negative bacteria, phages also adsorb in different manners. 
 The Gram-negative bacteria cell wall consists of an inner membrane and an outer 
membrane containing lipopolysaccharides (LPS), with a layer of peptidoglycan in the 
periplasmic space between the two (15). Peptidoglycan (PG), also known as murein, is a polymer 
made of glycan strands connected by short peptides and gives the cell shape and mechanical 
integrity (16). In these Gram-negative bacteria, proteins in the outer membrane, such as 
transmembrane proteins, as well as components of the LPS can act as receptors for 
bacteriophages (14).  
 Gram-positive bacteria, on the other hand, lack an outer membrane and have a much 
thicker cell wall, composed of peptidoglycan and teichoic acid (15). Phage adsorption on these 
phages typically rely on components of the teichoic acid formula and acetyl groups in muramic 
acid, although proteins, likely for transport, in the cell wall of some Gram-positive bacteria can 
also be phage receptors (14, 17).  
 Some phages also adsorb to slime or capsular polysaccharides, flagella, or pili of bacteria. 
Phages such as ΦAcM4 and ΦAcS2 in Asticcacaulis biprosthecum have sites connecting the 
head and tail of the virus to host flagella; since the distant end of the tail remains free to adsorb, 
it is thought that the phage moves along the flagella towards the cell itself (18). Bacteria also 
may produce protective layers, such as capsules or slimes, and some phages have adapted to be 
able to adsorb to antigens or enzymes in these protective layers (14). More well-known are the 
two types of phages which adsorb to retractable sex pili (19). Filamentous phages adsorb to 
either F pili, the sex pilus in Escherichia coli, produced by the conjugative plasmid F in male 
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(F+) strains, or the sex factor I, produced by colI (20). These phages adsorb to the tip of the pili, 
preventing conjugation, before their DNA enters the host cell (21). It is proposed that as the pili 
is retracted into the host, the phage genetic material is also drawn in (22). Single-stranded RNA 
phages also adsorb to the sex pilus via a maturation protein, and hundreds of virions can actually 
attach to a pilus at the same time (23). The exact mechanism of RNA injection is unknown, but 
after absorption, the phage RNA is able to enter the host cell along with the maturation protein 
(24).  
Double-stranded DNA phages can be either virulent or temperate, and they follow 
different replication strategies. Virulent phages like T4 enter immediately to the lytic cycle, in 
which the genes needed to produce viral progeny are expressed, and those phage particles are 
eventually released to the environment upon cell lysis. Temperate phages like λ, however, can 
enter the lysogenic cycle. When a phage undergoes lysogeny, the phage genome integrates into 
the host chromosome as a prophage, replicating with the host, and excises under stress 
conditions, at which point it enters the lytic cycle (25). Through mainly transcriptomic 
regulation, these phages have the ability to control and time gene expression. Often, they use 
host machinery to express early genes and begin replication before producing polymerases and 
other enzymes for transcription and translation of phage DNA (26). This allows for proper 
timing, so that replication will precede production of phage heads, tails, and tail fibers, which 
must be able to assemble into progeny with phage DNA packaged before cell lysis (27). 
 Unlike the dsDNA phages, small lytic phages with single-stranded genomes lack this 
kind of transcriptional regulation; however, at least for ssRNA phages, it is believed that 
translation of genes is regulated by the RNA secondary structure (28). Bacterial hosts must also 
still lyse to release ssRNA phage progeny out into the environment.  
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Not all bacteriophages lyse the host cell; filamentous phages like coliphage f1 are 
nonlytic, instead continually producing progeny which extrude out from the membrane into the 
environment by an unknown process, while the host cell remains alive. However, most phages 
end their life cycle by somehow disrupting the cell membrane of the bacterial host in order to kill 
the cell and release virions, and this project focuses on this ultimate step. 
Double-stranded DNA phage lysis 
 In Gram-negative bacteria, double-stranded DNA phages follow a three step lysis process 
(29). First, Phages form holes in the inner membrane first with a holin, which then leads to the 
degradation of PG by endolysins, but there are two separate ways this can be achieved. In 
canonical holin-endolysin lysis, studied in λ, holin proteins accumulate in the inner membrane 
until triggered, when they aggregate into large rafts and form micron-scale holes (30). The 
endolysin proteins in the cytoplasm can then escape into the periplasm and start degrading PG 
(29). Alternatively, the pinholin/SAR endolysin pathway occurs when pinholins, which forms 
much smaller (around 2 nm), more numerous rafts than the canonical holins, are triggered, 
depolarizing the membrane (31-33). SAR endolysins, unlike the canonical endolysins, are 
actually secreted by the host sec system and remain in an inactive form, tethered to the inner 
membrane; this depolarization by pinholins cause the SAR endolysins to change conformation, 
becoming active, released from the inner membrane (34). However, the outer membrane remains 
intact, preventing the cell from lysing. This is remedied with spanin proteins, which are proposed 
to fuse the inner and outer membranes together, and are either unimolecular (u-spanins) or two-
component (i-spanins and o-spanins) (35). The lysis genes encoding for these proteins are often, 
but not always, close together on the phage genome, forming a cassette (36). 
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Single-stranded RNA phage lysis  
Unlike large double-stranded DNA phages which encode three to six lysis proteins, these 
phages – along with some single-stranded DNA phages – have single gene lysis systems, in 
which the product of just one gene causes lysis the bacterial cell (37). The interaction between 
the one phage lysis and a target in the bacterial host will cause cell death and lysis, which could 
potentially open the door to identifying new targets for antibiotics.  
Each ssRNA phage has three core genes, mat, coat, and rep, coding for the maturation 
protein which recognizes the sex pilus, coat protein which composes the capsid, and an RNA-
dependent RNA polymerase, respectively. Although these genes have high sequence homology 
from one ssRNA phage to the next, the lysis gene varies greatly and has almost no similarity 
between phages. There are four paradigm single gene lysis systems, for which the lysis 
mechanism is known for three: A2 from ssRNA phage Qβ, Lys from ssRNA phage M, and E 
from ssDNA phage ϕX174 (Fig 1). The lysis proteins from these three phages inhibit enzymes 
M 
(ssRNA) 
Figure 1 Genome organization of the paradigm phages with single gene lysis systems 
lys 
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involved in the biosynthesis of peptidoglycan (Fig 2). Lysis protein A2 from Qβ inhibits MurA, 
which catalyzes the first step in PG biosynthesis pathway, while E from ϕX174 inhibits MraY, 
which forms the first lipid-linked intermediate in the pathway (38, 39). Lys, the lysis protein 
from M, was recently found to block MurJ, an enzyme which flips peptidoglycan from the 
cytosol into the periplasm (unpublished data). The fourth paradigm single gene lysis system is L, 
discovered in 1979, from ssRNA phage MS2  (40). Despite the studies performed with MS2 – 
most recently focusing on its structure, RNA encapsidation, and potential as a scaffold for drug 
delivery – the lytic function of MS2 has still not been determined (41, 42). Unlike A2, Lys, and E, 
which cause septal collapse, L produces random blebbing, a different lysis phenotype. With 
septal collapse, blebbing occurs at the mid-cell region where the septum forms during cell 
Figure 2 Peptidoglycan biosynthesis pathway, with ssRNA phage lysis proteins known to inhibit enzymes 
in the pathway shown. Enzymes shown were created with UCSF Chimera (1). 
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division, while in random blebbing, as the name suggests, blebs are inconsistent, forming in 
various regions around the cell. This suggests L may target an entirely different pathway, but the 
lysis mechanism of L has remained unsolved for nearly 40 years.  
Novel ssRNA phage genomes 
Only fourteen ssRNA phages and 3 ssDNA phages with these single gene lysis systems 
were previously known, limiting the studies of their diverse lysis mechanisms. However, over 
150 novel phage genomes were isolated from transcriptomic and environmental metadata within 
the past year (2, 3). The phage genomes were identified through sequence homology of the three 
core genes, but just one of  those genomes had an annotated lysis gene, a cistron that  was 40% 
similar to but much longer than MS2 L (2). This is in part because of the extremely high 
mutation frequency; the genetic architecture (i.e., sequence, size and position within the genome) 
of the lysis gene varies greatly from phage to phage, and homology between lysis genes is 
uncommon. As a result, a new bioinformatics approach must be taken to identify novel lysis 
genes. In addition, the lysis genes from these ssRNA phages may provide insight into novel ways 
to kill bacteria or help find new antibiotic targets. 
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CHAPTER II 
METHODS 
 
Culture growth and bacterial strains 
 Except when specified, LB and agar were used as the growth medium. Antibiotics used 
when appropriate were ampicillin (Amp) at 100 ug/mL, kanamycin (Kan) at 40 ug/mL, 
chloramphenicol (Cam) at 10 ug/mL, and tetracycline (Tet) at 10 µg/mL. 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside (X-Gal), Isopropyl β-D-thiogalactopyranoside (IPTG), and 
arabinose were added as needed at a final concentration of 1 mM, 10 µg/ml and 0.4%, 
respectively.  E. coli XLI-Blue was the bacterial strain used in these experiments, unless 
otherwise indicated. 
Annotation of lysis gene candidates 
Novel ssRNA phage sequences discovered by Krishnamurthy et al. and Shi et al. were 
manually annotated for potential lysis genes using Artemis, a genome browser and annotation 
tool from the Sanger Institute. The three core genes, mat, coat, and rep, were previously 
annotated based on sequence homology (2, 3). Lysis gene candidates were selected based on 
TMHMM analysis and the Shine-Dalgarno sequence, the ribosomal binding site, of open reading 
frames greater than 25 nucleotides. 
Synthesis of lysis genes and cloning 
 Lysis gene candidates, flanked by EcoRI and XhoI restrictions sites, with a HindIII site a 
few nucleotides downstream, were constructed in groups of gBlocks from Integrated DNA 
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Technologies. GBlocks from Integrated DNA Technologies were also used to synthesize 
modified lysis genes for added protein tags, linkers, or nucleotide changes in the lysis proteins.  
 For newly synthesized lysis gene candidates, a lacZα gene was inserted using XhoI and 
HindIII sites. EcoRI and HindIII sites were used to insert genes into an ampicillin-resistant 
pBad24 vector. Enzymes were purchased from New England Biolabs, and ligation was 
performed following manufacturer instructions. Plasmids were transformed into bacteria using 
standard methods.  
Testing potential lysis genes 
Bacteria with inserted plasmids were streaked simultaneously on LB inducer plates (Amp 
and arabinose) and non-inducer (Amp) plates. DNA from colonies on the non-inducer plates, 
which also showed growth defects on inducer plates, was extracted using the Qiagen Miniprep 
protocol and sequenced through Eton Biosciences. A modified blue-white suppressor screen, in 
which the plasmid vector carried a lacZω, while the insert carried lacZα, was used to ensure 
presence of the inserts through blue colonies. 
Overexpression of MurJ and ectopic expression of Caulobacter crescentus MraY were 
achieved using expression from Amp-resistant pCM6 and Cam-resistant pZA22 vectors, 
respectively. Lysis genes were also expressed in E. coli strain TB28 with mraY replaced with the 
homologous gene from Caulobacter crescentus. 
Growth curves 
 Selected colonies were grown at 37℃ in 5 mL overnight cultures. Then, 25 mL cultures 
of LB supplemented with 100 ug/mL ampicillin were inoculated with a 1:200 dilution of the 
15 
overnight cultures and grown at 37℃. The culture growth and lysis were monitored at an 
absorbance of 550 nm (A550) as previously described (43). At time 0, when A550 ~0.2, the 
cultures were induced with arabinose. Absorbance measurements were taken at specific time 
intervals post induction. 
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CHAPTER III 
RESULTS 
 
Genomes annotated for lysis gene candidates 
 Potential lysis genes were annotated in 90 out of the 188 novel ssRNA phage genomes 
previously identified, yielding 126 lysis gene candidates (2, 3). Multiple novel genetic 
architectures were found in terms of the location of the lysis gene, e.g. in the +1 reading frame of 
coat or partially embedded in rep (Fig. 3). These genes were manually annotated based on open 
reading frames greater than 25 codons with strong Shine-Dalgarno sequences and 
transmembrane domains. While not all ssRNA phage lysis proteins are transmembrane, most of 
the lysis genes from previously known ssRNA phages have predicted transmembrane domains, 
allowing us to use this parameter to narrow down potential candidates. That said, 5 of the 
genomes annotated had no good candidates with a transmembrane domain, and the annotated 
Figure 3 Examples of novel genetic architectures found. 
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lysis gene candidates had strong other indicators, like a good start codon and ribosomal binding 
site. 
Novel lysis genes produce growth defects or lysis 
Furthermore, 55 of the lysis gene candidates were synthesized and expressed in E. coli; 
five were shown to cause growth defects or lysis on plates. However, when growth curves were 
done in liquid media, two showed partial lysis (AIN003 lys and EMS 003 lys) while the 
remaining three did not show any growth defect (Fig. 4). EMS003 lys is embedded in the +1 
Figure 4 Lysis curves of E. coli with novel lysis genes expressed 
 
Figure 5 Amino acid sequence of lysis proteins from EMS003 and AIN003. Predicted transmembrane 
domains are underlined, and positively and negatively charged amino acids are highlighted in blue and 
red, respectively. 
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reading frame of the replicase gene and encodes for a 52-amino acid protein with a predicted 
transmembrane. AIN003 Lys also has a predicted transmembrane domain, but is only 27 amino 
acids in length, shorter than any previously known lysis protein; the gene itself is separate, 
upstream of the maturation protein (Fig. 5).  
EMS003 Lys targets Caulobacter crescentus MraY 
 Although EMS003 Lys shows partial lysis in E. coli, it is similar in terms of genomic 
architecture to ΦCb5, a Caulobacter crescentus phage; both lysis genes are in an embedded +1 
reading frame of the replicase gene (44). In addition, the lysis protein of ΦCb5 is similar to that 
of E, which targets E. coli MraY. Because the original host of the phage EMS003 is unknown, 
EMS003 was tested in an E. coli strain with MraY replaced with the MraY from C. crescentus. 
When EMS003 lys was expressed in this strain, there was complete lysis in comparison to the 
partial lysis originally seen (Fig. 6). This suggests that EMS003 lys targets C. crescentus MraY, 
and that C. crescentus may be the phage’s original host.  
Figure 6. (A) Lysis curve of EMS003 lys expressed in E. coli XLIBlue strain, with uninduced culture 
as negative control. (B) Lysis curve of EMS003 lys expressed in E. coli strain TB28 with a 
CcMraY::Kan gene replacement, with an uninduced culture as negative control. 
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AIN003 Lys does not target MraY or MurJ 
 In contrast, AIN003 Lys does not target either transmembrane protein known to be part 
of the PG biosynthesis pathway. Overexpression of MurJ has been shown to rescue bacteria from 
lysis caused by Lys from phage M (unpublished data). However, when MurJ is overexpressed 
with AIN003 Lys, lysis still occurs (Fig. 7a). Similarly, the expression of MraY protein from 
Caulobacter crescentus has been shown to rescue lysis from E, from ΦX174 (unpublished data). 
However, this also did not rescue lysis from AIN003 Lys (Fig. 7b).  
 
  
Figure 7. (A) Lysis curve of AIN003 lys with MurJ overexpressed on a plasmid, and negative control. 
(B) Lysis curve of AIN003 lys with C. crescentus MraY expressed on a plasmid, with negative 
control. 
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CHAPTER IV 
CONCLUSION 
 
Because so few ssRNA phages were previously known, the identification of so many 
novel ssRNA phage genomes in the past year opens the door for studying the diversity of these 
viruses’ lysis genes. The lack of sequence similarity and placement within the genome of these 
lysis genes hint at a range of lysis mechanisms, which may provide novel antibiotic strategies or 
locate a new target for antibiotics.  
Lysis gene candidates that were annotated were open reading frames greater than 25 
codons and had a strong ribosomal binding site and predicted transmembrane domain, like lysis 
genes already known. However, it is highly likely that there are lysis proteins from these phages 
that are soluble (like A2 from Qβ), especially as at least five of the genomes had potential lysis 
gene candidates without a transmembrane domain, based on near-consensus Shine-Dalgarno 
sequences and strong probabilities out of all open reading frames in their respective genomes. 
Although we only identified two lysis genes that showed a lysis phenotype in liquid 
culture, it is critical to note that the original hosts of the novel phages remain unknown as they 
were pulled from environmental metadata. The lysis gene candidates annotated were only 
expressed in E. coli, and those negative for lysis may likely be from a different host.  
EMS003 Lys, even though it targets MraY from C. crescentus, like ΦX174 E in E. coli, 
the two lysis genes share no significant sequence similarity, and likely interact with the target in 
differing ways. AIN003 Lys, despite having a predicted transmembrane domain, does not target 
the two known transmembrane proteins in the PG biosynthesis pathway, suggesting either that 
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the protein itself is soluble despite the strong prediction or that it targets an entirely different 
pathway or protein. This is of considerable interest as there is no single lysis protein yet 
identified that can kill and lyse the bacterial cell through a mechanism outside of PG 
biosynthesis. 
Future goals include annotation of more of the recently identified ssRNA phage genomes, 
and synthesizing lysis gene candidates from those genomes. Any novel lysis genes found in E. 
coli will be tested in a comparable manner to EMS003 lys and AIN003 lys. Further investigation 
into the C. crescentus MraY – EMS003 Lys interaction will be done as well. Steps will be taken 
to achieve better lysis with AIN003 Lys. 
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